Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07296770 · ClinicalTrials.gov registry record · Phase 3
An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service
A Phase 3 study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- Phase 3
- Development phase
- 126
- Enrollment target
NCT07296770: Clinical Trial Phase 3 study, sponsored by University of California, San Francisco.
NCT07296770 is a Phase 3 study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 126 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07296770, a Phase 3 study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 126 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn whether a pain-management program called a Transitional Pain Service can help prevent long-term pain and reduce opioid needs after surgery in adult surgical patients who may be at higher risk for developing persistent pain. The main questions this trial aims to answer are: 1) Does the Transitional Pain Service help high-risk surgical patients manage pain better after surgery? 2) Can a computer tool (an algorithm) improve screening of patients for long-lasting pain after surgery? The investigators will compare patients who continue with their usual care to patients who receive support from the Transitional Pain Service to see if the program leads to better pain control and lower opioid use. Participants will share information about their pain levels and the pain-relief treatments they are using before and after surgery so researchers can better understand how the program affects recovery. Patients assigned to the Transitional Pain Service will also be offered additional coordinated support before and after their surgery to help optimize their pain control and overall recovery.
Primary Outcome
This outcome measures how many patients in each group (Standard of Care vs. Transitional Pain Service) have chronic post-surgical pain 90 days after date of surgery. Chronic post-surgical pain refers to pain that starts after surgery and lasts longer than 3 months, gets worse after 3 months, or spreads to nearby nerves or areas connected to the surgical site. To make this diagnosis, other causes-such as infection, cancer, or pain conditions from before surgery-must be ruled out.
Interventions
- BEHAVIORAL Physical Therapy
- DEVICE TPS-Select
- DRUG Pharmacologic Pain Management
- PROCEDURE Interventional Pain Procedures
- BEHAVIORAL Psychological Management and Pain Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-07-01 |
| Phase | Phase 3 |
What is known before NCT07296770 opens enrollment
NCT07296770 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 5 interventions - of which Physical Therapy is the first listed.
NCT07296770 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07296770 about?
NCT07296770 is a clinical study titled "An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service". The goal of this clinical trial is to learn whether a pain-management program called a Transitional Pain Service can help prevent long-term pain and reduce opioid needs after surgery in adult surgical patients who may be at higher risk for developing persistent pain. The main questions this trial ai...
What is the current status of trial NCT07296770?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 126 participants. The study started on 2026-05-01. Estimated completion is 2028-07-01.
What interventions are being tested in trial NCT07296770?
The interventions under investigation include: Physical Therapy (BEHAVIORAL), TPS-Select (DEVICE), Pharmacologic Pain Management (DRUG), Interventional Pain Procedures (PROCEDURE), Psychological Management and Pain Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT07296770?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07296770's enrollment target sits among peer trials
126 1603rd of 2000 higher than 396 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI